Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855510) titled 'A Clinical Trial of V175 and V175A in Healthy Adults' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Merck Sharp & Dohme LLC
Condition:
Lower Respiratory Tract Infection
Intervention:
Biological: V175
Biological: V175A
Biological: Control Vaccine
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 27, 2026
Target Sample Size: 564
To know more, visit https://clinicaltrials.gov/study/NCT078555...